Baxter has sold its Renal Care Division to Carlyle for $3.8 Billion

Baxter has sold its Renal Care Division to Carlyle for $3.8 Billion

(AP Photo/Mel Evans) Copyright 2008 AP. All rights reserved. This content may not be published, published, rewritten or redistributed. On August 13, 2024, Baxter International Inc. (NYSE: BAX, $36.12, Market Capitalization: $18.4 billion), a global leader in medtech, and funds managed by global investment firm Carlyle (NASDAQ: CG) announced that they have signed a definitive … Read more